POTASSIUM CITRATEEXTENDED RELEASE (Vensun Pharmaceuticals, Inc)
Welcome to the PulseAid listing for the POTASSIUM CITRATE drug offered from Vensun Pharmaceuticals, Inc. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Vensun Pharmaceuticals, Inc |
| NON-PROPRIETARY NAME: | POTASSIUM CITRATE |
| SUBSTANCE NAME: | POTASSIUM CITRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-07-07 |
| END MARKETING DATE: | 0000-00-00 |
POTASSIUM CITRATE EXTENDED RELEASE HUMAN PRESCRIPTION DRUG Details:
| Item Description | POTASSIUM CITRATE EXTENDED RELEASE from Vensun Pharmaceuticals, Inc |
| LABELER NAME: | Vensun Pharmaceuticals, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(meq/1) |
| START MARKETING DATE: | 2016-07-07 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42543-406_5a974f0a-c6ed-404e-9dfd-b6742cc83b09 |
| PRODUCT NDC: | 42543-406 |
| APPLICATION NUMBER: | ANDA206813 |
Other POTASSIUM CITRATE Pharmaceutical Manufacturers / Labelers:
